NCT00848289View on ClinicalTrials.gov

Genetic Susceptibility to Bladder Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

6,086

Participants

Timeline

Start Date

February 10, 1998

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
Bladder Cancer
Interventions
BEHAVIORAL

Interviews

Data collected by personal interview for Epidemiology and Nutrition Questionnaires, with personal and follow-up telephone interviews.

Trial Locations (2)

77030

Baylor College of Medicine, Houston

MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00848289 - Genetic Susceptibility to Bladder Cancer | Biotech Hunter | Biotech Hunter